AzTrials
AzTrials

Immediate Dental ImplantsNCT06773104

Autogenous Tooth Bone Graft Versus Allogeneic Bone Graft Around Dental Implant in Aesthetic Zone

A study testing immediate implant with allogenic bone graft and Allogeneic bone graft with immediate implant placement in people with Immediate Dental Implants and Thin Labial Plate of Bone Pre-extraction, run by Tanta University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

24 patienta with non restorable anterior teeth underwent extraction with immediate implant installation using bone grafts either autogenous tooth bone graft or allogenic bone graft Autogenous tooth bone graft group (study group): 12 patients will have immediate implant placement with autogenous tooth bone graft. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
What is being tested?
immediate implant with allogenic bone graft and Allogeneic bone graft with immediate implant placement
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteEgypt
Study dates
25 Mar 2024to 16 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients with non restorable maxillary anterior teeth need to be extracted.
  • Thin labial plate of bone of the tooth to be extracted.
  • Patients age above 20years old.
  • Good oral hygiene.
  • No signs of acute infection or inflammation

Who cannot join

  • Prior radiation therapy.
  • Soft and hard tissue pathology at the operation site.
  • Any relevant systemic disease or medication that might compromise bone healing.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry

    Tanta, 3111

Other trials in Egypt

About this study

24 patienta with non restorable anterior teeth underwent extraction with immediate implant installation using bone grafts either autogenous tooth bone graft or allogenic bone graft Autogenous tooth bone graft group (study group): 12 patients will have immediate implant placement with autogenous tooth bone graft.

  • Allogeneic bone graft group (control group): 12 patients will have immediate implant placement with allogeneic bone graft (demineralized freeze dried bone allograft - cortico cancellous).
Read the detailed description

24 patienta with non restorable anterior teeth underwent extraction with immediate implant installation randomized to two groups Autogenous tooth bone graft group (study group): 12 patients will have immediate implant placement with autogenous tooth bone graft.

  • Allogeneic bone graft group (control group): 12 patients will have immediate implant placement with allogeneic bone graft (demineralized freeze dried bone allograft - cortico cancellous). preparation of autogenous tooth bone graft Any restorations, caries, cementum, periodontal ligament and pulp tissue will be removed .The tooth will be grinded using dental bone mill and bone crusher Tooth particles will be sieved to particles size 300 to 1200 microns. The sorted particles will be immersed in 70 % ethanol and 5% Peracetic acid* in a sterile container for 10 minutes to remove any soft tissue remnants, bacteria and smear layer (defatting and sterilization).

Tooth particles will be demineralized using 2% HNO3for 20 minutes to expose the dentine organic matrix.

The bacteria-free particulate dentin will be washed with phosphate buffered saline‡ twice for 5 minutes to restore the PH balance to 7.4. In the same setting, surgical procedure after atraumatic extraction immediate implant willbe inserted according to dimensions taken from CBCT and jumbing gap will be filled with bone graft according to randomization

Being tested
immediate implant with allogenic bone graft, Allogeneic bone graft with immediate implant placement
Keywords
autogenous tooth bone graft, allogenic bone graft, grafting the jumbing gap, immediate dental implant

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • immediate implant with allogenic bone graftProcedure or surgery

    after atraumatic extraction immediate implant will be inserted with allogenic bone graft

  • Allogeneic bone graft with immediate implant placementProcedure or surgery

    Immediate dental implant placement with grafting of the jumping gap using allogeneic bone graft (DFDBA).

Study groups in NCT06773104
Study groupRoleWhat they receive
Autogenous tooth bone graft groupExperimentalTwelve patients receiving immediate implant placement with autogenous fresh partially demineralized dentin graft.
Receives: Procedure: Allogeneic bone graft with immediate implant placement
Allogeneic bone graft group (control group)Active comparatorPatients receiving immediate dental implant placement with allogeneic bone graft (DFDBA) for grafting of the jumping gap.
Receives: Procedure: immediate implant with allogenic bone graft

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. labial bone thickness

    measuring thickness of labial bone labial to the implant

    Measured: 6 months

  2. marginal bone loss

    Measured: 6 months

Secondary outcomes (3)
  1. bone density around dental implant

    bone density will be assessed using CBCT buccal to the implant fixtures 6 months after implant installation

    Measured: 6 months

  2. implant secondary stability

    Implant stability will be assessed at the time of implant insertion and 6 months after the operation. Resonance frequency analysis (RFA) values expressed as implant stability quotient (ISQ) will be recorded by a transducer attached to the implant by a screw and a frequencyresponse analyzer (Osstell Mentor Device) with the average of 2measurements performed with the probe in 2 perpendiculardirections

    Measured: 6 months

  3. implant success

    when the following clinical features arise: emerging of the fistula, the particle of the bone graft material flow out from the fistula or mucosal dehiscence, and the chronic inflammation ragarded as failure

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2025
  2. Study start25 Mar 2024
  3. Primary completion16 Oct 2025
  4. Study completion16 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
non restorable anterior teeth with thin labial plate of bone
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06773104
Sponsor's protocol ID
diab123
Status last verified
Jan 2026
First submitted
30 Dec 2024
Last updated
20 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing immediate implant with allogenic bone graft and Allogeneic bone graft with immediate implant placement in people with Immediate Dental Implants and Thin Labial Plate of Bone Pre-extraction, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

labial bone thickness (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in